Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Healthspan Capital is a venture capital firm founded in 2021 and headquartered in El Cerrito, California. The firm is dedicated to investing in the burgeoning field of longevity biotechnology, often referred to as 'LongBio'. With a mission to support companies that are developing therapeutics aimed at extending healthy human lifespan, Healthspan Capital positions itself at the forefront of a rapidly evolving sector. Although specific quantitative metrics such as fund size and portfolio count are not publicly available, the firm is recognized for its active engagement in the longevity biotech space. The leadership team comprises experienced general partners and advisors who bring a wealth of knowledge and expertise in biotechnology, enhancing the firm's reputation as a valuable partner for early-stage companies. Healthspan Capital's strategic focus on North America allows it to tap into a rich ecosystem of innovation and research, making it an attractive option for startups in the longevity sector.
Healthspan Capital specializes in early-stage investments within the longevity biotechnology sector, specifically targeting companies in the pre-Seed to Series A stages. The firm employs a diversified investment strategy, seeking out a variety of methodologies and approaches that contribute to the development of therapeutics aimed at extending healthy human lifespan. This focus on 'LongBio' allows Healthspan Capital to support a range of innovative companies that are pioneering advancements in healthspan and lifespan research. By concentrating on early-stage ventures, the firm aims to identify and nurture groundbreaking ideas that have the potential to transform the biotechnology landscape. Healthspan Capital is particularly interested in companies that demonstrate a strong commitment to scientific rigor and innovation, as well as those that align with its mission of enhancing human health through longevity.
To pitch Healthspan Capital, founders should visit their website at healthspancapital.vc or reach out via email at info@healthspancapital.vc. They are open to pitches from early-stage companies in the longevity biotechnology sector, and it is advisable to include a clear overview of the business model and the innovative aspects of the technology being developed.
Healthspan Capital invests in companies at the pre-Seed to Series A stages. This focus allows them to support early-stage ventures that are developing innovative solutions in the longevity biotechnology sector.
The firm exclusively focuses on longevity biotechnology, also known as 'LongBio'. This sector encompasses a range of companies that are working on therapeutics aimed at extending healthy human lifespan.
Specific information regarding typical check sizes is not publicly available. However, as a venture capital firm, Healthspan Capital is likely to provide funding that aligns with the needs of early-stage companies in the longevity biotech space.
Healthspan Capital primarily invests in North America, with a particular emphasis on the United States. This geographic focus allows them to engage with a robust ecosystem of biotech innovation.
Founders interested in pitching to Healthspan Capital can do so through their website at healthspancapital.vc or via email at info@healthspancapital.vc. They welcome pitches from early-stage longevity biotech companies.
While specific details about portfolio support are not mentioned, Healthspan Capital is known for its active engagement with its portfolio companies, leveraging its network and expertise in the longevity sector to assist in their growth and development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.